Outsense Diagnostics Ltd.

Lifebond Ltd

Other

Eximore Ltd.

Ishay Attar

Natalie Iram

Orahn Preiss-Bloom

Yaara Kapp-Barnea

Izhar Halahmi

Eyal Sheetrit

Chagai Komlos

Meir Haber

Orahn Preiss Bloom

Apparatus and methods are described for use with a bodily emission of a subject that is disposed within a toilet bowl. One or more light sensors are configured to receive light from the toilet bowl, while the bodily emission is disposed within the toilet bowl. A computer processor detects a set of three or more spectral components that have a characteristic relationship with each other in a light spectrum of a microorganism, by analyzing the received light, and determines that there is a presence of the microorganism within the bodily emission in response thereto. Other applications are also described.

Bodily emission analysis

Apparatus and methods are described for use with a bodily emission of a subject that is disposed within a toilet bowl. While the bodily emission is disposed within the toilet bowl, light is received from the toilet bowl using one or more light sensors. Using a computer processor, intensities of at least two spectral bands that are within a range of 530 nm to 785 nm are determined, by analyzing the received light, and a ratio of the intensities of the two spectral bands is determined. In response thereto, the computer processor determines that there is a presence of blood within the bodily emission. The computer processor generates an output on an output device, at least partially in response thereto. Other applications are also described.

In some embodiments, the present invention is a composition, including: a bulking agent, where the bulking agent is a kaolin, an absorbent material, where the absorbent material is a fumed silica, a binder, where the binder is an epoxy, and a first active agent, where the first active agent is Latanoprost.

Devices and methods for delivering a bio-active agent or bio-active agents

Apparatus and methods are described for use with feces of a subject that are disposed within a toilet bowl. One or more light sensors receive light from the toilet bowl, while the feces are disposed within the toilet bowl. A computer processor detects a set of three or more spectral components that have a characteristic relationship with each other in a light spectrum of bile, by analyzing the received light, and detects a presence of bile within the feces, in response to detecting the set of three or more spectral components. The computer processor generates an output in response thereto. Other applications are also described.

Apparatus and methods are described for use with feces of a subject that are disposed within a toilet bowl, and an output device. One or more light sensors are configured to receive light from the toilet bowl, while the feces are disposed within the toilet bowl. A computer processor analyzes the received light, and, in response thereto, detects a currently-occurring inflammatory bowel disease episode, and/or a predicted upcoming inflammatory bowel disease episode. The computer processor generates an output on the output device, at least partially in response thereto. Other applications are also described.

Apparatus and methods are described for use with feces of a subject that is disposed within a toilet bowl (), and an output device (). One or more light sensors () receive light from the toilet bowl, while the feces are disposed within the toilet bowl. A computer processor () analyzes the received light, and, in response thereto, determines that there is a presence of blood within the feces, and determines a source of the blood from within the subject's gastrointestinal tract. The computer processor () generates an output on the output device (), at least partially in response thereto. Other applications are also described.

Apparatus and methods are described for use with a bodily emission of a subject that is disposed within a toilet bowl. While the bodily emission is disposed within the toilet bowl, light is received from the toilet bowl using one or more light sensors. Using a computer processor, one or more spectral components within the received light that are indicative of light absorption by a component of erythrocytes are detected, by analyzing the received light. In response thereto, the computer processor determines that there is a presence of blood within the bodily emission. The computer processor generates an output on an output device, at least partially in response thereto. Other applications are also described.

Apparatus and methods are described for use with a bodily emission () of a subject that is disposed within a toilet bowl. While the bodily emission is disposed within the toilet bowl (), light is received from the toilet bowl using one or more light sensors (). Using a computer processor (), one or more spectral components within the received light that are indicative of light absorption by a component of erythrocytes are detected, by analyzing the received light. In response thereto, the computer processor determines that there is a presence of blood within the bodily emission. The computer processor generates an output on an output device (), at least partially in response thereto. Other applications are also described.

Methods for delivering a bio-active agent or bio-active agents to an eye of a mammal

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

Gelatin-transglutaminase hemostatic dressings and sealants

Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).

Growing community of inventors

Haifa, Israel

Ishay Attar